Stock Updates

Is this Large Market Cap Stock target price reasonable for Teva Pharmaceutical Industries Limited (NYSE:TEVA)?

The company in question is, Teva Pharmaceutical Industries Limited (NYSE:TEVA) currently with a stock price of 54.61 (0.55% today). The market cap for Teva Pharmaceutical Industries Limited is 50091.2, and is in the sector Healthcare, and Drug Manufacturers – Other industry. The target price for Teva Pharmaceutical Industries Limited is 71.05. Currently Teva Pharmaceutical Industries Limited is trading with a P/E of 28.27, and a forward P/E of 9.06. Average volume for Teva Pharmaceutical Industries Limited is 6192.37 and so far today it is 2085043.

Performance in the last year for Teva Pharmaceutical Industries Limited has been -22.78%. For EPS growth, Teva Pharmaceutical Industries Limited has seen a growth of -48.90%, and is looking to grow in the next year to 13.12%. More long term stats show that EPS growth has been -13.10% over the last five years and could be 5.23% for the next five years. Teva Pharmaceutical Industries Limited has seen sales growth quarter over quarter at -3.50%, with EPS growth quarter over quarter at 19.10%. The 20-day simple moving average is 4.51%, with the 200-day simple moving average coming to -4.07%.

Since the IPO date for Teva Pharmaceutical Industries Limited on the 3/26/1990, Teva Pharmaceutical Industries Limited has seen performance year to date to be -16.21%. With Teva Pharmaceutical Industries Limited trading at 54.61, the dividend yield is 2.50%, and the EPS is 1.92.

So could Teva Pharmaceutical Industries Limited, be undervalued? Well as said before P/E is 28.27. The PEG is 5.4, P/S is 2.57 and the P/B is at 1.63. The P/cash is 8.4, with P/free cash flow at *TBA.

Teva Pharmaceutical Industries Limited ability to deal with debt shows that the current ratio is 1.3, and the quick ratio is 1. This is with long term debt/equity at 0.28, and total debt/equity at 0.34.

In terms of margins, Teva Pharmaceutical Industries Limited has a gross margin of 58.10%, an operating margin of 19.30% and a profit margin of 8.70%.Payout ratio for Teva Pharmaceutical Industries Limited is 70.10%. Return on assets come to 3.30% with return on investment coming to 5.70%.

Insider ownership for Teva Pharmaceutical Industries Limited, is at 2.70% and institutional ownership comes to 65.80%. Outstanding shares are at 922.32. While shares float is 914.06. The float short is currently 2.18%, and short ratio is 3.22.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment